Correlation Engine 2.0
Clear Search sequence regions


  • benin (1)
  • donor (1)
  • Gavi (5)
  • haiti (1)
  • nepal (1)
  • tajikistan (1)
  • tanzania (5)
  • vaccines (5)
  • Sizes of these terms reflect their relevance to your search.

    Vaccines have produced remarkable impact in reducing the global burden of disease. Thanks to Gavi-the Vaccine Alliance, which supports eligible countries to increase access to the new and underused vaccines. Gavi support depends on economic growth, whereby low-income countries contribute 0.2 USD per dose of supported vaccines, while middle-income countries contribute by price fraction that increases gradually by 15% annually. A country must become fully self-financing within five years when its economy reaches 1,630 USD GNI per capita. Recently, Tanzania, Benin, Haiti, Nepal, and Tajikistan became middle-income countries triggering gradual reduction in Gavi support. This paper first compares the socio-demographic characteristics, immunization program performance, and health financing strategies of these countries and second, explores domestic financing strategies that Tanzania can use to close the funding gap. Although the five countries are similar economically, they vary in demography, health financing strategies, extent of donor dependency, and strength of immunization programs. Some health indicators are not any better than those in low-income countries. Tanzania receives the largest financial support from Gavi and is projected to be fully self-financing by 2043. The potential domestic funding opportunities include to increase Government budget, use of innovative financing strategies, and health insurance, complemented with enhanced program efficiency. Copyright © 2022 Elsevier Ltd. All rights reserved.

    Citation

    Amani Thomas Mori, Ngwegwe Christopher Bulula, Richard Magodi, William Mwengee. Domestic funding opportunities for Tanzania as five new Middle-Income countries brace for reduced Gavi support for immunization. Vaccine. 2022 May 26;40(24):3278-3285

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 35527062

    View Full Text